• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Gold Moves Lower; Lululemon Shares Plummet

    3/22/24 2:50:14 PM ET
    $CUTR
    $IDN
    $ISPR
    $LULU
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Computer Software: Prepackaged Software
    Technology
    Get the next $CUTR alert in real time by email

    U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining around 0.3% on Friday.

    The Dow traded down 0.49% to 39,585.67 while the NASDAQ rose 0.26% to 16,444.91. The S&P 500 also rose, gaining, 0.01% to 5,241.56.

    Check This Out: These 3 Risk Off Stocks With Over 3% Dividend Yields Are Recommended By Wall Street's Most Accurate Analysts

     

    Leading and Lagging Sectors

     

    Communication services shares jumped by 0.8% on Friday.

    In trading on Friday, real estate shares fell by 1.1%.

     

    Top Headline

     

    Shares of Lululemon Athletica Inc. (NASDAQ:LULU) fell more than 15% during Friday’s session after releasing fourth-quarter results.

    Lululemon posted better-than-expected results for its fourth quarter, but issued a weak forecast for the first quarter.

    The company said it sees first-quarter revenue in the range of $2.175 billion to $2.2 billion versus estimates of $2.25 billion. The company anticipates first-quarter earnings of $2.35 to $2.40 per share versus estimates of $2.55 per share, according to data from Benzinga Pro.

     

    Equities Trading UP

     

    Summit Midstream Partners, LP (NYSE:SMLP) shares shot up 38% to $26.85 after the company announced the sale of its Utica position for $625 million.

    Shares of Outlook Therapeutics, Inc. (NASDAQ:OTLK) got a boost, surging 19% to $8.40 after the company announced it received a positive European Union CHMP opinion for ONS-5010 as a treatment for Wet AMD.

    Intellicheck, Inc. (NASDAQ:IDN) shares were also up, gaining 70% to $2.98 after the company reported a year-over-year increase in fourth-quarter EPS results.

     

    Equities Trading DOWN

     

    Cutera, Inc. (NASDAQ:CUTR) shares dropped 29% to $1.6391 after the company reported worse-than-expected fourth quarter adjusted EPS results.

    Shares of Sintx Technologies, Inc. (NASDAQ:SINT) were down 31% to $0.0941 after the company announced a proposed public offering of common stock.

    Ispire Technology Inc. (NASDAQ:ISPR) was down, falling 26% to $5.97 after the company announced the pricing of its public offering of 2.05 million shares of common stock at $6.00 per share.

    Also Check This Out: Top 3 Materials Stocks That Could Blast Off In Q1

     

    Commodities

     

    In commodity news, oil traded down 0.5% to $80.63 while gold traded down 0.9% at $2,164.20.

    Silver traded down 0.6% to $24.85 on Friday, while copper fell 1.2% to $4.0090.

     

    Euro zone

     

    European shares were mixed today. The eurozone’s STOXX 600 fell 0.03%, London’s FTSE 100 jumped 0.61% while Spain’s IBEX 35 Index rose 0.70% The German DAX rose 0.15% French CAC 40 fell 0.34% while Italy’s FTSE MIB Index rose 0.05%.

    The Ifo Business Climate indicator for Germany climbed to 87.8 in March from February's revised reading of 85.7. German import prices declined 5.9% year-over-year in January.

    Retail sales volumes in the UK came in unchanged for February, while UK’s GfK Consumer Confidence indicator came in flat at -21 in March.

     

    Asia Pacific Markets

     

    Asian markets closed mixed on Friday, with Japan’s Nikkei 225 gaining 0.18%, Hong Kong’s Hang Seng Index falling 2.16%, China’s Shanghai Composite Index falling 0.95% and India’s S&P BSE Sensex gaining 0.26%.

    Foreign direct investment into China dipped by 19.9% year-over-year to CNY 215.1 billion during the first two months of the year. The annual inflation rate in Japan accelerated to 2.8% in February from 2.2% a month ago.

     

    Economics

     

    The total number of active U.S. oil rigs fell by 1 rig this week, Baker Hughes Inc reported.

    Now Read This: Around $5M Bet On This Communication Services Stock? Check Out These 4 Stocks Insiders Are Buying

    Get the next $CUTR alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CUTR
    $IDN
    $ISPR
    $LULU

    CompanyDatePrice TargetRatingAnalyst
    lululemon athletica inc.
    $LULU
    1/8/2026Hold
    Deutsche Bank
    lululemon athletica inc.
    $LULU
    12/12/2025$170.00Underperform → Hold
    Jefferies
    lululemon athletica inc.
    $LULU
    12/12/2025$200.00 → $215.00Market Perform
    Telsey Advisory Group
    lululemon athletica inc.
    $LULU
    12/10/2025Neutral
    Guggenheim
    Intellicheck Inc.
    $IDN
    11/13/2025$7.00Market Perform → Outperform
    Northland Capital
    lululemon athletica inc.
    $LULU
    10/20/2025$146.00Underperform → Neutral
    BNP Paribas Exane
    lululemon athletica inc.
    $LULU
    10/16/2025$190.00Outperform → Mkt Perform
    Bernstein
    lululemon athletica inc.
    $LULU
    9/25/2025Buy → Hold
    Needham
    More analyst ratings

    $CUTR
    $IDN
    $ISPR
    $LULU
    SEC Filings

    View All

    Outlook Therapeutics Inc. filed SEC Form 8-K: Other Events

    8-K - Outlook Therapeutics, Inc. (0001649989) (Filer)

    2/11/26 5:00:40 PM ET
    $OTLK
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 10-Q filed by Ispire Technology Inc.

    10-Q - Ispire Technology Inc. (0001948455) (Filer)

    2/6/26 4:30:49 PM ET
    $ISPR
    Medicinal Chemicals and Botanical Products
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Outlook Therapeutics Inc.

    SCHEDULE 13G/A - Outlook Therapeutics, Inc. (0001649989) (Subject)

    2/5/26 11:48:52 AM ET
    $OTLK
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $CUTR
    $IDN
    $ISPR
    $LULU
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Outlook Therapeutics Submits Type A Meeting Request to FDA Following Complete Response Letter

    ISELIN, N.J., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (NASDAQ:OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced that it has submitted a Type A meeting request to the U.S. Food and Drug Administration (FDA) following receipt of a Complete Response Letter (CRL) dated December 30, 2025, regarding the Company's Biologics License Application (BLA) for ONS-5010/LYTENAVA™ (bevacizumab-vikg) for the treatment of wet age-related macular degeneration (wet AMD). The CRL identified a single deficiency based on a purported lack of substantial evidence of effectiveness, and recommended

    2/11/26 8:45:00 AM ET
    $OTLK
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    lululemon Introduces Unrestricted Power™ — A New Sensation for Strength Training

    Unrestricted Power features a new proprietary fabric innovation and performance-led design to deliver an unmatched combination of support, mobility, and on-body feel The training assortment was developed with lululemon Ambassadors, including Lewis Hamilton & Kayla Jeter lululemon (NASDAQ:LULU) today unveiled Unrestricted Power™, a new innovation platform engineered for heavy lifts and demanding gym sessions. The assortment, which launches this morning in North America, is backed by thousands of hours of research and development, providing secure support without compromising comfort and mobility, enabling a distraction-free fit built to match every move. This press release features mult

    2/10/26 8:30:00 AM ET
    $LULU
    Apparel
    Consumer Discretionary

    Ispire Technology Inc. Reports Financial Results for Fiscal Second Quarter 2026

    Ongoing Focus on Collections Drives 19% Reduction in Net Accounts Receivable since June 30, 2025Cash of $17.6 Million at December 31, 2025  LOS ANGELES, Feb. 6, 2026 /PRNewswire/ -- Ispire Technology Inc. (NASDAQ:ISPR) ("Ispire," the "Company," "we," "us," or "our"), an innovator in vaping technology and precision dosing, today reported financial results for the second quarter of fiscal 2026, for the three months ended December 31, 2025. Fiscal Second Quarter 2026 Financial Results Revenue of $20.3 million versus $41.8 million for the second quarter of fiscal 2025.Gross profit

    2/6/26 7:00:00 AM ET
    $ISPR
    Medicinal Chemicals and Botanical Products
    Health Care

    $CUTR
    $IDN
    $ISPR
    $LULU
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Chief Financial Officer Trask Kevin

    4 - Sintx Technologies, Inc. (0001269026) (Issuer)

    2/10/26 8:45:54 PM ET
    $SINT
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Chairman, President and CEO Olson Eric K.

    4 - Sintx Technologies, Inc. (0001269026) (Issuer)

    2/10/26 8:44:43 PM ET
    $SINT
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Chief Investment Officer Honigblum Gregg R.

    4 - Sintx Technologies, Inc. (0001269026) (Issuer)

    2/10/26 8:43:48 PM ET
    $SINT
    Medical/Dental Instruments
    Health Care

    $CUTR
    $IDN
    $ISPR
    $LULU
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Investment Officer Honigblum Gregg R. bought $34,896 worth of shares (8,200 units at $4.26), increasing direct ownership by 4% to 201,067 units (SEC Form 4)

    4 - Sintx Technologies, Inc. (0001269026) (Issuer)

    12/9/25 8:00:05 AM ET
    $SINT
    Medical/Dental Instruments
    Health Care

    Chief Investment Officer Honigblum Gregg R. bought $255,350 worth of shares (65,000 units at $3.93) and was granted 53,867 shares, increasing direct ownership by 161% to 192,867 units (SEC Form 4)

    4 - Sintx Technologies, Inc. (0001269026) (Issuer)

    12/8/25 8:00:03 AM ET
    $SINT
    Medical/Dental Instruments
    Health Care

    Director Smith Guy L bought $6,180 worth of shares (1,000 units at $6.18), increasing direct ownership by 0.26% to 392,948 units (SEC Form 4)

    4 - Intellicheck, Inc. (0001040896) (Issuer)

    11/25/25 1:21:07 PM ET
    $IDN
    Computer Software: Prepackaged Software
    Technology

    $CUTR
    $IDN
    $ISPR
    $LULU
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Deutsche Bank initiated coverage on lululemon athletica

    Deutsche Bank initiated coverage of lululemon athletica with a rating of Hold

    1/8/26 10:59:22 AM ET
    $LULU
    Apparel
    Consumer Discretionary

    lululemon athletica upgraded by Jefferies with a new price target

    Jefferies upgraded lululemon athletica from Underperform to Hold and set a new price target of $170.00

    12/12/25 8:37:05 AM ET
    $LULU
    Apparel
    Consumer Discretionary

    Telsey Advisory Group reiterated coverage on lululemon athletica with a new price target

    Telsey Advisory Group reiterated coverage of lululemon athletica with a rating of Market Perform and set a new price target of $215.00 from $200.00 previously

    12/12/25 8:16:51 AM ET
    $LULU
    Apparel
    Consumer Discretionary

    $CUTR
    $IDN
    $ISPR
    $LULU
    Leadership Updates

    Live Leadership Updates

    View All

    WM Technology, Inc. Appoints Harry DeMott and Brent Cox to Board of Directors and Announces Executive Employment Arrangement with CFO Susan Echard

    WM Technology, Inc. ("WM Technology" or the "Company") (NASDAQ:MAPS), a leading marketplace and technology solutions provider to the cannabis industry, today announced the appointment of Harry DeMott and Brent Cox to the Company's Board of Directors, effective February 1, 2026. The Company also announced that Susan Echard will continue to serve as Chief Financial Officer, transitioning from a contracted arrangement to employment with the Company, effective January 30, 2026. "We are pleased to welcome Harry and Brent to WM Technology's Board of Directors. They each bring a combination of cannabis industry perspective, technology fluency, and disciplined capital markets experience," said Do

    2/3/26 5:45:00 PM ET
    $ISPR
    $MAPS
    Medicinal Chemicals and Botanical Products
    Health Care
    Computer Software: Prepackaged Software
    Technology

    Outlook Therapeutics Appoints Laura Cantrell as Vice President of Corporate Strategy and Business Development

    ISELIN, N.J., Jan. 06, 2026 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (NASDAQ:OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced it has appointed Laura Cantrell as Vice President of Corporate Strategy and Business Development. "We are very pleased to welcome Laura to Outlook Therapeutics at such a pivotal time in our evolution," said Bob Jahr, Chief Executive Officer of Outlook Therapeutics. "Laura's two decades of global biotechnology experience spanning corporate strategy, business development and portfolio leadership, and her proven ability to identify, evaluate and execute high-value

    1/6/26 8:35:00 AM ET
    $OTLK
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    lululemon Appoints Ranju Das as the Company's First Chief AI & Technology Officer

    20+ Year Technology Executive Brings Deep Experience Across Enterprise Systems, Digital Innovation, and AI and Machine Learning lululemon (NASDAQ:LULU) today announced that it has appointed Ranju Das as Chief AI & Technology Officer, effective September 2, 2025. In this newly created role, Mr. Das will be responsible for leading the company's technology organization and driving the development and execution of the next phase of lululemon's technology and AI strategy. He will report to Chief Executive Officer, Calvin McDonald, and will join the company's Senior Leadership Team. "We see an exciting opportunity to further leverage AI and technology to advance our product innovation process

    8/26/25 6:30:00 AM ET
    $LULU
    Apparel
    Consumer Discretionary

    $CUTR
    $IDN
    $ISPR
    $LULU
    Financials

    Live finance-specific insights

    View All

    Ispire Technology Inc. Reports Financial Results for Fiscal Second Quarter 2026

    Ongoing Focus on Collections Drives 19% Reduction in Net Accounts Receivable since June 30, 2025Cash of $17.6 Million at December 31, 2025  LOS ANGELES, Feb. 6, 2026 /PRNewswire/ -- Ispire Technology Inc. (NASDAQ:ISPR) ("Ispire," the "Company," "we," "us," or "our"), an innovator in vaping technology and precision dosing, today reported financial results for the second quarter of fiscal 2026, for the three months ended December 31, 2025. Fiscal Second Quarter 2026 Financial Results Revenue of $20.3 million versus $41.8 million for the second quarter of fiscal 2025.Gross profit

    2/6/26 7:00:00 AM ET
    $ISPR
    Medicinal Chemicals and Botanical Products
    Health Care

    Ispire Technology Inc. Schedules Fiscal Second Quarter 2026 Earnings Conference Call

    LOS ANGELES, Feb. 3, 2026 /PRNewswire/ -- Ispire Technology Inc. ("Ispire" or the "Company") (NASDAQ:ISPR), a trailblazer in vaping technology and precision dosing, announced today that it will host its earnings conference call at 8:00 am ET on Friday, February 6, 2026, to discuss the Company's financial results for its fiscal second quarter ended December 31, 2025. To listen to the conference call, please dial in using the information below. When prompted upon dialing-in, please ask for the "Ispire Technology Call." Date: Friday, February 6, 2026Time: 8:00 am ETDial-In Number

    2/3/26 7:00:00 AM ET
    $ISPR
    Medicinal Chemicals and Botanical Products
    Health Care

    Outlook Therapeutics Reports Financial Results for Fiscal Year 2025

    ISELIN, N.J., Dec. 19, 2025 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (NASDAQ:OTLK), a biopharmaceutical company focused on enhancing the standard of care for bevacizumab for the treatment of retina diseases, today announced financial results for fiscal year 2025. Financial Highlights for the Fiscal Year Ended September 30, 2025 For the fiscal year ended September 30, 2025, Outlook Therapeutics reported net loss attributable to common stockholders of $62.4 million, or $1.79 per basic and diluted share, and $1.4 million of revenue. This compares with net loss attributable to common stockholders of $75.4 million, or $4.06 per basic and diluted share, and no revenue for the prior year.

    12/19/25 8:05:00 AM ET
    $OTLK
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $CUTR
    $IDN
    $ISPR
    $LULU
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Intellicheck Inc.

    SC 13G/A - Intellicheck, Inc. (0001040896) (Subject)

    11/15/24 7:00:49 AM ET
    $IDN
    Computer Software: Prepackaged Software
    Technology

    Amendment: SEC Form SC 13G/A filed by SiNtx Technologies Inc.

    SC 13G/A - Sintx Technologies, Inc. (0001269026) (Subject)

    11/14/24 7:25:52 PM ET
    $SINT
    Medical/Dental Instruments
    Health Care

    Amendment: SEC Form SC 13G/A filed by Outlook Therapeutics Inc.

    SC 13G/A - Outlook Therapeutics, Inc. (0001649989) (Subject)

    11/14/24 4:55:26 PM ET
    $OTLK
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care